This Amendment is solely for the purpose of adding the Financial
Data Schedule.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-QSB/A
(Mark One)
( X ) QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE
ACT OF 1934
For the quarterly period ended: March 31, 1996
( ) TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE EXCHANGE ACT
For the transition period from: to
Commission file number: 0-13265
UCI MEDICAL AFFILIATES, INC,
(Exact name of small business issuer as specified in its charter)
<TABLE>
<CAPTION>
Delaware 59-2225346
<S> <C>
(State or other jurisdiction of incorporation (IRS Employer Identification No.)
or organization)
</TABLE>
6168 St. Andrews Road, Columbia, SC 29212
(Address of principal executive offices)
(803) 772-8840
(Issuer's telephone number)
(Former name, address or fiscal year, if changed since last report)
Check whether the issuer (1) filed all reports required to be filed by Section
13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days. ( X )YES ( ) NO
APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
PROCEEDINGS DURING THE PRECEDING FIVE YEARS
Check whether the registrant filed all documents and reports required to be
filed by Section 12, 13, or 15(d) of the Exchange Act after the distribution of
securities under a plan confirmed by a court. ( )YES ( ) NO
APPLICABLE ONLY TO CORPORATE ISSUERS
State the number of shares outstanding of each of the issuer's classes of common
equity, as of the latest practicable date:
4,291,553 shares of $.05 common stock outstanding at March 31, 1996
Transitional Small Business Disclosure Format (check one): ( )YES ( X ) NO
1
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
UCI Medical Affiliates, Inc.
(Registrant)
/S/ M.F. MCFARLAND, III, M.D. /S/ JERRY F. WELLS, JR.
Marion F. McFarland, III, M.D. Jerry F. Wells, Jr.
President, Chief Executive Officer, Vice President of Finance and
and Chairman of the Board Chief Financial Officer
Date: May 30, 1996
1
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> DEC-31-1995
<PERIOD-END> MAR-31-1996
<CASH> 174,160
<SECURITIES> 0
<RECEIVABLES> 3,998,904
<ALLOWANCES> 934,519
<INVENTORY> 267,356
<CURRENT-ASSETS> 4,417,011
<PP&E> 4,762,037
<DEPRECIATION> 1,710,946
<TOTAL-ASSETS> 12,689,053
<CURRENT-LIABILITIES> 3,556,905
<BONDS> 4,731,270
0
0
<COMMON> 214,578
<OTHER-SE> 5,800,874
<TOTAL-LIABILITY-AND-EQUITY> 12,689,053
<SALES> 0
<TOTAL-REVENUES> 5,909,220
<CGS> 0
<TOTAL-COSTS> 5,133,453
<OTHER-EXPENSES> 272,321
<LOSS-PROVISION> 212,788
<INTEREST-EXPENSE> 137,456
<INCOME-PRETAX> 153,202
<INCOME-TAX> 0
<INCOME-CONTINUING> 153,202
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 153,202
<EPS-PRIMARY> .04
<EPS-DILUTED> .04
</TABLE>
